Mackenzie Financial Trims ResMed Stake

Asset manager reduces position in medical equipment provider by over a third

Mar. 13, 2026 at 10:06am

Got story updates? Submit your updates here. ›

Mackenzie Financial Corp. has reduced its stake in ResMed Inc. (NYSE: RMD), a leading medical equipment provider, by 36.2% during the third quarter. The firm now owns 159,896 shares of ResMed, down from 250,706 shares previously.

Why it matters

ResMed is a major player in the sleep apnea and respiratory device market, and changes in institutional ownership can signal shifts in investor sentiment around the company's performance and outlook.

The details

According to a regulatory filing, Mackenzie Financial sold 90,810 shares of ResMed during the third quarter. The asset manager now owns approximately 0.11% of ResMed's outstanding shares, valued at $43.8 million as of the most recent filing.

  • Mackenzie Financial reduced its ResMed stake during the third quarter of 2026.

The players

Mackenzie Financial Corp

A Canadian asset management firm that has reduced its position in medical equipment provider ResMed Inc.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Mackenzie Financial's ResMed stake could signal a shift in investor sentiment around the medical device company, though the reasons behind the portfolio change are not entirely clear from the limited information provided. Ongoing performance and market trends for ResMed will be important to monitor going forward.